Eckoh (ECK)

Sector:

Support

Index:

FTSE AIM All-Share

40.00p
   
  • Change Today:
    -0.50p
  • 52 Week High: 45.50
  • 52 Week Low: 34.00
  • Currency: UK Pounds
  • Shares Issued: 290.44m
  • Volume: 159,744
  • Market Cap: £116.18m
  • RiskGrade: 83

Small caps round-up: ReNeuron, Eckoh, Healthcare Locums

Date: Tuesday 14 Aug 2012

LONDON (ShareCast) - Clinical-stage stem cell group ReNeuron surged on Tuesday after saying that the Data Safety Monitoring Board gave a favourable recommendation to proceed to the with a higher dose of its ReN001 stem cell therapy in a clinical trial. 'This represents a further important milestone for the study as we make our plans for a subsequent Phase II clinical trial application with ReNeuron's ReN001 cell-based treatment for stroke disability,' said ReNeuron's Chief Executive Michael Hunt.

The therapy is being administered in ascending doses to a total of 12 stroke patients who have been left disabled by an ischaemic stroke. The group also announced that one patient in the trial has now been successfully treated with ReN001 and discharge from hospital with no acute safety issues arising. Shares jumped 14.91% to 3.7p.

Speech recognition and payment solutions group Eckoh has secured a two-year contract with UK baby website Kiddicare to provide secure card payment services over the phone. "This is the second EckohPROTECT contract to be secured in quick succession through the new referral agreement with a global service provider that was announced in May 2012," the firm said. Shares were up 7.84% at 13.75p.

Healthcare Locums, the nursing, media and social services recruitment group, saw shares rocket 23.29% to 2.25p today after announcing that it would not bother filing a defence against legal claims in the US as it has no interests in the country and therefore does not abide by US law. The complaint accuses the company and some of its former directors of making "misrepresentations" during 2012 concerning its profitability and accounting practices, something that the firm disagrees with.

The group told the plaintiffs' US counsel that the underlying claim is "wholly without merit and that if proceedings are commenced in the proper forum they will be strenuously defended."

BC

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Eckoh Market Data

Currency UK Pounds
Share Price 40.00p
Change Today -0.50p
% Change -1.23 %
52 Week High 45.50
52 Week Low 34.00
Volume 159,744
Shares Issued 290.44m
Market Cap £116.18m
RiskGrade 83

Eckoh Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
73.61% below the market average73.61% below the market average73.61% below the market average73.61% below the market average73.61% below the market average
62.22% below the sector average62.22% below the sector average62.22% below the sector average62.22% below the sector average62.22% below the sector average
Price Trend
23.74% below the market average23.74% below the market average23.74% below the market average23.74% below the market average23.74% below the market average
32.65% below the sector average32.65% below the sector average32.65% below the sector average32.65% below the sector average32.65% below the sector average
Income
42.28% below the market average42.28% below the market average42.28% below the market average42.28% below the market average42.28% below the market average
50% below the sector average50% below the sector average50% below the sector average50% below the sector average50% below the sector average
Growth
51.67% above the market average51.67% above the market average51.67% above the market average51.67% above the market average51.67% above the market average
29.29% above the sector average29.29% above the sector average29.29% above the sector average29.29% above the sector average29.29% above the sector average

What The Brokers Say

Strong Buy 2
Buy 1
Neutral 0
Sell 0
Strong Sell 0
Total 3
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Eckoh Dividends

  Latest Previous
  Final Final
Ex-Div 21-Sep-23 21-Sep-22
Paid 20-Oct-23 21-Oct-22
Amount 0.74p 0.67p

Trades for 10-May-2024

Time Volume / Share Price
16:37 50,000 @ 40.00p
15:58 5,000 @ 39.12p
15:40 15,000 @ 40.00p
14:49 34 @ 40.00p
14:18 50 @ 40.00p

Eckoh Key Personnel

CEO Nicolas B Philpot
CFO Chrissie Herbert

Top of Page